Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 31

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 31
---
 Board; |

| • | annually reviewing, discussing and assessing the performance of our Board, including Board committees, seeking input from senior management, the full Board and others; |

| • | recommending annually to our Board for its approval the Chair and membership of each committee; |

| • | ensuring that all new directors receive a comprehensive orientation and that all new directors fully understand the nature and operation of our business, the role of our Board and its committees, and the contribution that each new director is expected to make, including the commitment of time and resources; |

| • | overseeing periodic evaluations of management succession plans; and |

| • | developing and reviewing a set of corporate governance principles for us. |

A copy of our Corporate Governance and Nominating Committee’s charter is available on our website at www.arbutusbio.com. Our Board is responsible for approving nominees for election as directors. However, as is described above, our Corporate Governance and Nominating Committee is responsible for reviewing, soliciting and recommending nominees to our Board. Board and Committee Meetings During the fiscal year ended December 31, 2024, our Board held a total of 9 meetings (in person or by teleconference). Our Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee met a total of 4, 4, and 3 times, respectively. Each director attended at least 75% of the total number of meetings of our Board and committee meetings of which such director was a member during 2024. Board Member Attendance at Annual Shareholder Meetings Although we do not have a formal policy regarding director attendance at annual general meetings of Shareholders, directors are invited to attend these annual general meetings. Of the directors serving at the time of our 2024 Annual General and Special Meeting of Shareholders, only Michael McElhaugh attended such Meeting; none of our current directors were serving on our Board at such time. Corporate Governance Guidelines In June 2021, our Board adopted corporate governance guidelines (the “Guidelines”) as a general framework to assist the Board in carrying out its oversight responsibilities and to serve our best interests, managed by or under the direction of our Board. The Guidelines are available on our website at www.arbutusbio.com. The Guidelines provide that the responsibilities of the Board include, among other things, strategic planning and budgeting, review of corporate performance, the appointing of a Chair of the Board and our executive officers, corporate disclosure, systems integrity, and reviewing material transactions. The Corporate Governance and Nomin